yes, you spent from 2006 to 2018 working for glaxosmithkline.— for glaxosmithkline.hkline. yes, i was global president of _ for glaxosmithkline. yes, i was global president of research - for glaxosmithkline. yes, i was| global president of research and development for them. and global president of research and development for them.- global president of research and development for them. and this is the neriod development for them. and this is the period with _ development for them. and this is the period with which _ development for them. and this is the period with which we - development for them. and this is the period with which we are - development for them. and this is the period with which we are mostj the period with which we are most concerned. — the period with which we are most concerned, in april 2018 your career took another turn and you were appointed — took another turn and you were appointed on that date as government chief scientific adviser and you reniained — chief scientific adviser and you remained in that post until march thi5 remained in that po

line yes, i was glaxosmithkline.e yes, i was global president of research and development for them. >> and then and this, of course, is the period with which we are most concerned in april 2018, in your career took another turn and you were appointed on that date as government chief scientific adviser , and you scientific adviser, and you remained in that post until march of this year? yes that is just given us fact. >> where is the interroge notion about whether he had a conflict of interest? if you have £600,000 worth of shares in glaxo smithkline, you want people to be locked down. one might say, and therefore you want them to only released want them to only be released when is available. when your vaccine is available. and put in charge of and he was put in charge of the vaccine task force. so me vaccine task force. so tell me how that line questioning is how that line of questioning is not pursued now. >> you see, personally i don't >> you see, i personally i don't i don't know. vallance very well, but i don't t

>> had £650,000 worth of >> yes, he had £650,000 worth of shares in glaxosmithkline, and then he wasf the vaccine taskforce and he no one asked him about. >> well, it was raised, sarah, but he wasn't challenged as to whether appropriate. whether it was appropriate. >> i mean, you know , we've >> yeah. i mean, you know, we've got a lot of there are a lot of questions that need to be answered . and i think, you know, answered. and i think, you know, answered. and i think, you know, a lot for a lot of people, lockdown was what it was. a lot of people lot of money of people made a lot of money out of it. yeah. >> yeah, yeah. >> yeah, yeah. >> i mean, the sunday >> well, i mean, the sunday papers are filled every week, aren't they? we aren't they? and then we had matt who was health matt hancock, who was the health secretary, his mate who ran the local yeah. got contract local pub. yeah. got a contract for, for ppe. >> i don't asked about that. >> i don't be asked about that. >> i don't be asked about that. >> he's matt hancock is actually giving evidence to covid inquiry thursday end thu